MedTrace Logo

Does Rapid Mobilisation Improve Length of Stay and Outcomes Post THR

NCT02428829 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 212

Last updated 2020-01-29

No results posted yet for this study

Summary

This study looks to examine the effect of attempting initial postoperative walking with a patient following a total hip replacement. Currently patients rest in bed for approximately 24 hours following their operation before walking. The intervention group would aim to commence walking at between 4-6 hours after their operation.

Outcome measures to be examined would be: length of hospital stay, patient experience of physiotherapy treatment, the time taken for patients to reach functional milestones and number of postoperative medical complications.

The study is designed as a randomised controlled trial where participants would be separated randomly into two groups. One group would form the intervention group and start physiotherapy and attempted walking 4-6 hours after their operation. The other group would form the control group and would remain on the current standard rehabilitation protocol.

Conditions

  • Arthroplasty, Replacement, Hip
  • Hip Replacement, Total

Interventions

PROCEDURE

Attempt walking from 4 hours post operatively, on the day of their surgery.

Intervention group will be seen by a physiotherapist to attempt walking from 4 hours post operatively, on the day of their surgery.

PROCEDURE

Control - standard treatment

standard physiotherapy in line with current hospital protocol including first walking approximately 24 hours post operatively.

Sponsors & Collaborators

  • The Royal Bournemouth Hospital

    lead OTHER

Principal Investigators

  • Christopher Efford, BSc(Hons) · Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2019-09-30
Completion
2019-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02428829 on ClinicalTrials.gov